Apolipoprotein(a) [apo(a)] is a glycoprotein with Mr %280,000 that is disulfide linked to apolipoprotein B in lipoprotein(a) particles. Elevated plasma levels of lipoprotein(a) are correlated with atherosclerosis. Partial amino acid sequence of apo(a) shows that it has striking homology to plasminogen. Plasminogen is a plasma serine protease zymogen that consists of five homologous and tandemly repeated do-
mains called kringles and a trypsin-like protease domain. The amino-terminal sequence obtained for apo(a) is homologous to the beginning of kringle 4 but not the amino terminus of plasminogen. Apo(a) was subjected to limited proteolysis by trypsin or V8 protease, and fragments generated were isolated and sequenced. Sequences obtained from several of these fragments are highly (77-100%) homologous to plasminogen residues 391-421, which reside within kringle 4. Analysis of these internal apo(a) sequences revealed that apo(a) may contain at least two kringle 4-like domains. A sequence obtained from another tryptic fragment also shows homology to the end of kringle 4 and the beginning of kringle 5. Sequence data obtained from two tryptic fragments show homology with the protease domain of plasminogen. One of these sequences is homologous to the sequences surrounding the activation site of plasminogen. Plasminogen is activated by the cleavage of a specific arginine residue by urokinase and tissue plasminogen activator; however, the corresponding site in apo(a) is a serine that would not be cleaved by tissue plasminogen activator or urokinase. Using a plasmin-specific assay, no proteolytic activity could be demonstrated for lipoprotein(a) particles. These results suggest that apo(a) contains kringle-like domains and an inactive protease domain.
For the past decade a significant correlation has been established between elevated lipoprotein(a) levels, coronary artery disease, and progression of atherosclerotic lesions (1) (2) (3) (4) (5) (6) (7) . These studies led to the conclusion that the presence of lipoprotein(a) should be considered as a high-risk factor for coronary artery disease and atherosclerosis. Although the function of lipoprotein(a) is unknown, the composition of lipoprotein(a) has been elucidated. The protein component of lipoprotein(a) is comprised of apolipoprotein B-100 (apoB-100) and a second protein called apolipoprotein(a) [apo(a)] (8-10). These two proteins are covalently linked by disulfide bonds that can be readily reduced to yield, upon centrifugation, apo(a) and a lipoprotein particle containing apoB-100 that has properties similar to low density lipoprotein (LDL) (11) (12) (13) . There are two apo(a) molecules and one apoB molecule per lipoprotein(a) particle (3) . It is thought that there are several isoforms of apo(a) having molecular weights ranging from 280,000 to 500,000 (10) (11) (12) (13) (14) (15) . All ofthese isoforms appear to be immunologically related (13) . To elucidate the function of apo(a), we have begun to sequence apo(a). We report here the results of the partial amino acid sequence of apo(a). This sequence shows striking homology to human plasminogen.
MATERIALS AND METHODS
Isolation of Lipoprotein(a) and Apo(a). One healthy female subject with elevated lipoprotein(a) levels served as donor for lipoprotein(a) isolation. Lipoprotein(a) was separated from plasma by a combination of density gradient and rate zonal ultracentrifugation (13) , and apo(a) was isolated from lipoprotein(a) using methods described (13) . In brief, solutions of lipoprotein(a) containing -2 mg of protein per ml in 0.15 M NaCl, 0.01% Na2EDTA, and NaN3 (pH 7.0) was made 0.01 M with respect to dithiothreitol. Reduction proceeded for 1 hr at room temperature in the dark before the reduced lipoprotein(a) was carboxymethylated with 0.03 M iodoacetic acid for -20 min at a constant pH of 8.0. The modified lipoprotein(a) was then dialyzed against 35% (wt/vol) NaBr, 0.01% Na2EDTA (pH 7.0). Reduced and carboxymethylated apo(a) was isolated from the lipoprotein particle by rate zonal centrifugation in a Beckman 6OTi rotor at 59,000 rpm for 60-75 min at 20°C. After dialysis against 0.15 M NaCl/0.01% Na2EDTA/NaN3, pH 7.0, the apolipoprotein was passed over anti-apoB-and anti-apolipoprotein A-I-Sepharose columns as a precautionary step to remove any contaminating apolipoprotein A-I or apoB peptides. Anti-apoB and antiapolipoprotein A-I antibodies were raised as described (13) . The pure apo(a) was then dialyzed against 0.20 mM Nethylmorpholine (pH 7.0), lyophilized, and stored at -70°C. The isolated apo(a) has a mobility faster than apoB-100 as determined by NaDodSO4 gradient gel electrophoresis on 2.0-16% gels; the estimated molecular weight is 280,000 (10, 13) .
Amino Acid Sequencing. Purified apo(a) (=0.2 nmol, -50 ,ug) was subjected to amino-terminal amino acid sequencing using an Applied Biosystems (Foster City, CA) gas-phase sequencer (16) . Limited proteolysis of apo(a) was carried out by incubating 500 ,ug of reduced and carboxymethylated apo(a) in 0.05 M Tris HCl, pH 7.4/0.15 M NaCl with either trypsin at S ,ug or V8 protease at 5 ug for 15 min at 37°C. Fragments generated by proteolysis of apo(a) were isolated either by NaDodSO4/PAGE followed by gel elution (17) 
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was monitored at 210 and 280 nm. TWQ V8 peptides (fragments land 2) and four tryptic fragments (tryptic peptides 1, 4-6) were isolated by gel elution, while tryptic fragments 2 and 3 were isolated by HPLC.
Affinity Chromatography. Lysine-Sepharose with a 6-aminohexanoic acid spacer arm was a gift fr'om Robert Wohl of the University of Chicago. Before application, lipoprotein(a) or LDL were 'dialyzed against 0.1 M sodium phosphate, pH 7.4, containing 0.01% Na2EDTA and 0.01% NaN3. Samples were applied to a column (1.5 x 10 cm), equilibrated in the same buffer, at a flow rate of 10 ml/hr and successively washed with 0.1 M sodium phosphate, with 0.5 M sodium phosphate, and again with 0.1 M sodium phosphate. Bound material was eluted with 0.2 M E-aminocaproic acid containing 0.1 M sodium phosphate (pH 7.4), 0.01% Na2EDTA, and 0.01% NaN3.
Immunoblotting. Gradient gel electrophoresis in the presence of NaDodSO4 on 2.0-16% polyacrylamide gels (Pharmacia) was carried out according to methods described (10) . For immunologial characterization, proteins were transferred to nitrocellulose using the Bio-Rad Trans-Blot cell as described (10) . Transfer was carried out at 50 V, overnight with cooling. Antigens were identified with a double-antibody technique using anti-mouse or anti-rabbit IgG coupled to horseradish peroxidase (Miles) using 4-chloronaphthol as the chromogen. Antiserum to apo(a) was prepared according to described procedures (10 
RESULTS
Partial Amino Acid Sequence ofApo(a). The amino-terminal amino acid sequence (15 residues) obtained for highly purified apo(a) is shown in Fig. 1 . Compuiter-aided analysis ofthis sequence revealed that it has striking homology with the serne protease zymogen plasminogen. Plasminogen consists of five' homologous and tandemly repeated regions called kringles followed by a trypsin-like domain at its carboxyl terminus. The kringle domains contain specific binding regions for fibrin, a2-antiplasmin, and lysine (18) (19) (20) (21) . The plasma proteases prothrombin, tissue plasminogen activator (t-PA), urokinase, andlfactor XII also contain kringle-like domains that have homology with plasminogen kringles (22) (23) (24) (25) . Of the 15 amino-terminal residue's of apo(a), 12 were identical matches with plasminogen residues 349-363. This region of plasminogen is not its amino terminus, but rather the beginning of kringle 4. It is unlikely that the sequence obtained for apo(a) is due to contamination since quantitative recovery from the sequencer was 70 and 50% on the first two cycles, respectively. Also, reduced apo(a) migrates as a single band with Mr =280,000 by NaDodSO4/PAGE with purity of 95% and no apparent bands with the molecular weights of plasminogen (92,000) or plasmin (62,000 and 25,000), nor were bands apparent with the molecular weight of a plasminogen fragment consisting of kringles 4, 5, and the protease domain. Furthermore, apo(a) that had been eluted from a polyacrylamide gel gave the same amino-terminal sequence (data not shown).
To obtain further peptide sequence, apo(a) was subjected to limited proteolysis by trypsin or V8 protease. Fragments generated were isolated by either NaDodSO4/PAGE gel elution (17) or IPLC. As shown in Fig. 1 , six trypsin and two V8 protease fragments yielded sequences that have striking homology to plasminogen. The amino-terminal sequences of V8 fragment 1 and tryptic fragments 1-3 were overlapping sequences that corresponded to residues 391-425 of plasminogen kringle 4 . The amino-terminal sequence of.V8 fragment 1 and tryptic peptide 1 were identical to the corresponding plasminogen sequence, whereas the sequence obtained-for tryptic peptides 2 and 3 were slightly different (Fig. 1) . Of the 31 amino acids identified by tryptic peptides 2 and 3, 7 residues varied from the corresponding plasminogen kringle-4 sequence (77% homology); two of the seven differences were conservative substitutions. The sequence of tryptic peptides 2 and 3 has a lower degree of homology to kringles 1, 2, 3, and 5 of plasminogen (61%, 55%, 55%, and 64%, respectively). This result suggests that tryptic peptides 2 and
GA HQ E VN LE P H VQ Fig. 2, lipoprotein(a) bound to a lysine-Sepharose column, was not eluted by 0.5 M sodium phosphate, but was eluted by 0.2 M e-aminocaproic acid. e-Aminocaproic acid competes with lysine for binding to plasminogen. When both plasminogen and lipoprotein(a) were bound to a lysineSepharose column and the column was eluted with a 0-10 mM e-aminocaproic acid gradient, we found that apo(a) eluted earlier (=1.8 mM) than plasminogen (=3.8 and 5.3 mM). LDL did not bind to lysine-Sepharose.
Immunological Cross-Reactivity of Lipoprotein(a) and Plasminogen. To test the possibility that apo(a) and plasminogen shared common antigenic determinants, lipoprotein(a) and plasminogen were subjected to NaDodSO4 gradient gel electrophoresis followed by immunoblotting. As seen in Fig. 3 , lipoprotein(a) reacted with an anti-plasminogen antibody and conversely plasminogen reacted with an anti-apo(a) antibody indicating that apo(a) and plasminogen share common epitopes. In addition, a monoclonal antibody (10-F-i) known to recognize an epitope in the kringle-4 region of human plasminogen reacted with lipoprotein(a) (Fig. 3A) . Neither factor VIII or t-PA antibodies detected apo(a).
DISCUSSION
Apo(a), a glycoprotein with a molecular weight ranging from 280,000 to 500,000, is disulfide linked to apoliprotein B of an LDL-like particle to yield the so-called lipoprotein(a) particle (10) (11) (12) (13) (14) (15) . Partial amino acid sequencing of apo(a) revealed significant homology to plasminogen, a serine protease zymogen of Mr 92,000. Plasminogen consists of five homologous and tandemly repeated domains called kringles and a trypsin-like protease domain (18) . The kringle domains have specific binding regions for fibrin, a2-antiplasmin, lysine, and co-aminocarboxylic acids (19) (20) (21) . Plasminogen kringles 1-4 bind lysine, with kringles 1 and 4 exhibiting the highest binding affinity for lysine (19) . Urokinase and t-PA activate plasminogen by cleaving a single peptide bond yielding active two-chain plasmin, which subsequently cleaves itself at lysine-77 generating a molecule of Mr 87,000 (26, 27) . Significantly, of more than 300 residues identified for apo(a), no unique sequences were revealed. However, the apo(a) iso-
Immunological cross-reactivity of lipoprotein(a) and plasminogen as determined by immunoblotting. Lipoprotein(a) [Lp(a)] and plasminogen were subjected to electrophoresis on a 2-16% polyacrylamide/NaDodSO4 gradient gel and transferred electrophoretically to nitrocellulose. The replicate nitrocellulose was divided into the following three sections: section A was developed with the monoclonal antibody to kringle 4 of plasminogen, section B with anti-plasminogen, and section C with anti-apo(a). Plasminogen concentrations in sections A, B, and C were 16, 2, and 16 ,ug, respectively, and lipoprotein(a) concentrations in sections A, B, and C were 10, 20, and 2 I&g, respectively. form sequenced here was the smallest (Mr, 280,000) form reported to date (10, 11, 13 (32) suggest that human fibroblasts bind and internalize lipoprotein(a) particles by mechanism(s) other than the LDL receptor. In addition, Armstrong et al. (12) have found that the binding of lipoprotein(a) particles to the LDL receptor is significantly increased when apo(a) is removed by reduction. These studies, however, are in contrast to Albers and coworkers (34) who suggest that the LDL receptor does bind lipoprotein(a) particles. Plasminogen has been shown to specifically bind human endothelial cells. e-Aminocaproic acid competes with this binding, suggesting that the kringle domains of plasminogen mediate its binding to these cells (33) . This result demonstrates the possible presence of cell surface receptors that recognize protein kringle domains. Since kringle 4 of plasminogen has been implicated in fibrin binding, apo(a) may also bind fibrin. Apo(a) could, therefore, direct lipoprotein(a) particles to sites of fibrin deposition (vascular injury) and thus provide a concentrated substrate for the acetyl-LDL receptor of macrophages.
Apart from the limited binding studies on lipoprotein(a), the normal physiological function of apo(a) also remains unknown. Even the existence or level of lipoprotein(a) in lipoprotein(a)-negative subjects remains uncertain. Lipoprotein(a)-positive subjects might over express a normal gene product, or apo(a) might result from a mutant plasminogenlike gene product that is susceptible to cross-linking to apoB. It is hoped that the data presented here, and the subsequent cloning of the apo(a) gene, will help to elucidate the function of lipoprotein(a) in normal lipid metabolism and in the development of atherosclerosis.
